Release Date: July 31, 2025
Expiration Date: July 31, 2026
Activity Overview
Recent findings indicate that hypercortisolism can be an underlying contributor to difficult-to-control type 2 diabetes (T2D), and it may occur with lower cortisol levels than noted in overt Cushing syndrome. In this program, expert faculty discuss new perspectives on the prevalence of mild hypercortisolism in T2D, appropriate ways to diagnose it, and recently presented data on medical management.
Target Audience
This educational curriculum is directed towards endocrinologists, diabetologists, primary care physicians, and other health care professionals involved in the diagnosis and management of hypercortisolism in patients with T2D, including, but not limited to, nurses, nurse practitioners, physician assistants, and registered nurses.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Describe the role of hypercortisolism in the development of type 2 diabetes
- Identify risk factors for hypercortisolism in patients with type 2 diabetes
- Apply screening recommendations to identify hypercortisolism in patients with type 2 diabetes
- Assess clinical trial data for therapies for hypercortisolism